We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGI
3001
DELISTED
MoneyGram International, Inc. New
MGI
-48,557
Closed -$506K
TCRR
3002
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-48,900
Closed -$74K
BRMK
3003
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
-24,677
Closed -$116K
MNTV
3004
DELISTED
Momentive Global Inc. Common Stock
MNTV
-78,199
Closed -$729K
AQUA
3005
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-589,981
Closed -$29.3M
RIDE
3006
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
-2,135
Closed -$22K
SEAC
3007
DELISTED
Seachange International Inc
SEAC
-4,095
Closed -$30K
ABB
3008
DELISTED
ABB Ltd
ABB
-163,494
Closed -$5.61M
AUD
3009
DELISTED
Audacy, Inc.
AUD
-20,319
Closed -$3K
VMGA
3010
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
-75,000
Closed -$778K
VMGAW
3011
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
-37,500
Closed -$2K
TA
3012
DELISTED
TravelCenters of America LLC
TA
-5,695
Closed -$493K
SUMO
3013
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-37,583
Closed -$451K
GVCIW
3014
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
-37,925
Closed -$3K
GVCI
3015
DELISTED
Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares
GVCI
-75,850
Closed -$799K
SVNA
3016
DELISTED
7 Acquisition Corp
SVNA
-76,050
Closed -$794K
SVNAW
3017
DELISTED
7 Acquisition Corp Warrant
SVNAW
-38,025
Closed -$4K
JNCE
3018
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-80,336
Closed -$149K
MAXR
3019
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-42,019
Closed -$2.15M
BBBY
3020
DELISTED
Bed Bath & Beyond Inc
BBBY
-14,325
Closed -$7K
FRC
3021
DELISTED
First Republic Bank
FRC
-244,040
Closed -$3.42M
OSH
3022
DELISTED
Oak Street Health, Inc.
OSH
-59,586
Closed -$2.31M
PRVB
3023
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-25,091
Closed -$605K
CSII
3024
DELISTED
Cardiovascular Systems, Inc.
CSII
-19,712
Closed -$392K
EUCRW
3025
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
-22,697
Closed -$1K

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.